We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBTX
1601
DELISTED
Veritex Holdings
VBTX
$3.5M ﹤0.01%
170,689
-190
-0.1% -$3.93K
FBRT
1602
Franklin BSP Realty Trust
FBRT
$646M
$3.5M ﹤0.01%
261,724
-253
-0.1% -$3.3K
HRMY icon
1603
Harmony Biosciences
HRMY
$2.28B
$3.5M ﹤0.01%
104,115
+3,570
+4% +$115K
RLJ icon
1604
RLJ Lodging Trust
RLJ
$1.67B
$3.49M ﹤0.01%
295,562
-8,379
-3% -$98.6K
ADEA icon
1605
Adeia
ADEA
$3.08B
$3.49M ﹤0.01%
319,858
+1,078
+0.3% +$12.6K
UVV icon
1606
Universal Corp
UVV
$1.17B
$3.49M ﹤0.01%
67,396
+227
+0.3% +$12.3K
KAMN
1607
DELISTED
Kaman Corp
KAMN
$3.47M ﹤0.01%
75,667
-1,657
-2% -$68K
TWST icon
1608
Twist Bioscience
TWST
$7.77B
$3.46M ﹤0.01%
100,967
+3,673
+4% +$133K
WT icon
1609
WisdomTree
WT
$3.32B
$3.45M ﹤0.01%
375,089
+1,421
+0.4% +$10.9K
BHE icon
1610
Benchmark Electronics
BHE
$2.95B
$3.44M ﹤0.01%
114,773
-6,442
-5% -$186K
SG icon
1611
Sweetgreen
SG
$654M
$3.44M ﹤0.01%
136,043
+3,223
+2% +$46.9K
DGII icon
1612
Digi International
DGII
$3.16B
$3.43M ﹤0.01%
107,376
+745
+0.7% +$20.8K
TILE icon
1613
Interface
TILE
$2.18B
$3.42M ﹤0.01%
203,414
-417
-0.2% -$5.77K
ECPG icon
1614
Encore Capital Group
ECPG
$2.05B
$3.42M ﹤0.01%
75,008
+230
+0.3% +$11.3K
BRSL
1615
Brightstar Lottery PLC
BRSL
$2.03B
$3.42M ﹤0.01%
151,179
+1,935
+1% +$48.5K
ACAD icon
1616
Acadia Pharmaceuticals
ACAD
$5.04B
$3.41M ﹤0.01%
184,379
+1,095
+0.6% +$27.1K
CRDO icon
1617
Credo Technology Group
CRDO
$45.5B
$3.41M ﹤0.01%
160,841
+13,153
+9% +$275K
DOCN icon
1618
DigitalOcean
DOCN
$15.4B
$3.4M ﹤0.01%
88,991
-335
-0.4% -$12.4K
TMDX icon
1619
Transmedics
TMDX
$3.02B
$3.39M ﹤0.01%
45,862
+301
+0.7% +$24.8K
QAT icon
1620
iShares MSCI Qatar ETF
QAT
$63.7M
$3.39M ﹤0.01%
192,023
+716
+0.4% +$12.7K
NATL icon
1621
NCR Atleos
NATL
$3.43B
$3.38M ﹤0.01%
171,168
-27,104
-14% -$580K
AI icon
1622
C3.ai
AI
$1.61B
$3.38M ﹤0.01%
124,772
-9,964
-7% -$280K
ACVA icon
1623
ACV Auctions
ACVA
$1.25B
$3.37M ﹤0.01%
179,526
+3,907
+2% +$61.2K
GH icon
1624
Guardant Health
GH
$22.7B
$3.37M ﹤0.01%
163,136
+3,890
+2% +$83.4K
AMSF icon
1625
AMERISAFE
AMSF
$523M
$3.36M ﹤0.01%
67,011
+9,365
+16% +$465K

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.